Neutrophil adhesion molecules in chronic hemodialysis patients. 1994

P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.

The expression of the adhesion molecules LFA-1 (CD11a-CD18), Mac-1 (CD11b-CD18), and LAM-1 on predialysis and intradialysis neutrophils (PMN) was analyzed by flow cytometry in 10 chronic hemodialysis patients (CHD) and compared with age-matched normal controls. All patients were dialyzed either with a polyacrylonitrile, or a polysulfone membrane. To appreciate the influence of the interdialytic time, we compared the samples of Monday (3 days without dialysis), with those of Wednesday (2 days without dialysis). A patient group not treated with recombinant human erythropoietin (rHuEPO) was also included to analyze the influence of r-HuEPO. We found on the predialysis and intradialysis samples that the expression of CD11a was not different in the CHD patients and in the normal controls. Hemodialysis was associated with a rapid and significant reduction in LAM-1 on the 15- and 30-min samples (p < 0.05). This reduction was only transient, and returned to near predialysis levels after 120 min dialysis. The MAC-1 increased significantly after 30 min dialysis (p < 0.01), and remained at the end of the dialysis procedure still substantially above the predialysis levels (p < 0.01). On the other hand, we have found a significant (p < 0.005) up-regulating of the MAC-1, and a down-regulating of the LAM-1 in the predialysis samples. We noticed further a significantly lower expression (82 +/- 9.6%) for LAM-1 in these predialysis samples (p < 0.005). These results demonstrate that 'high MAC-1, low LAM-1' neutrophils were not only a dialysis-related phenomenon, but that they were already present before the hemodialysis session, nor was there any difference between the interdialytic times or compared with the r-HuEPO treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
May 1997, Intensive care medicine,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
October 1998, Clinical and experimental immunology,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
March 2004, Pediatric nephrology (Berlin, Germany),
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
January 1995, Respiration; international review of thoracic diseases,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
September 1998, The International journal of artificial organs,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
January 1993, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
January 2008, American journal of nephrology,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
January 1995, Pathobiology : journal of immunopathology, molecular and cellular biology,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
July 2013, Respiratory research,
P Zachée, and R Daelemans, and P Pollaris, and M A Boogaerts, and R L Lins
November 1999, Clinical nephrology,
Copied contents to your clipboard!